Land: Verenigde Staten
Taal: Engels
Bron: NLM (National Library of Medicine)
HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONATE SODIUM - UNII:YSE9PPT4TH)
AX Pharmaceutical Corp
HYALURONATE SODIUM
HYALURONATE SODIUM 4.95 g in 5 g
NOT APPLICABLE
Bulk Ingredient For Animal Drug Compounding
X - HYALURONIC ACID SODIUM POWDER AX PHARMACEUTICAL CORP ---------- X AX Pharmaceutical Corp hyaluronic acid sodium powder PRODUCT INFORMATION PRODUCT T YPE BULK INGREDIENT ITE M CODE (SOURCE ) NDC:6 2157-10 3 ROUTE OF ADMINISTRATION NOT APPLICABLE ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH HYALURO NATE SO DIUM (UNII: YSE9 PPT4TH) (HYALURONATE SODIUM - UNII:YSE9 PPT4TH) HYALURONATE SODIUM 4.9 5 g in 5 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH WATER (UNII: 0 59 QF0 KO0 R) PRODUCT CHARACTERISTICS COLOR white (white) S CORE S HAP E S IZ E FLAVOR IMPRINT CODE CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 2157-10 3-0 1 5 g in 1 BOTTLE 0 5/22/20 15 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITA TIO N MARKE TING START DATE MARKE TING END DATE BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING 0 5/22/20 15 LABELER - AX Pharmaceutical Corp (202924858) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS AX Pharmaceutical Co rp 20 29 248 58 repack(6 2157-10 3) , relabel(6 2157-10 3) Revised: 5/2016 Lees het volledige document